Latest Strategic Partnerships News

Urbanise.com Limited reported 14.3% revenue growth to $15 million in FY2026, significantly narrowing its net loss to $0.9 million while advancing a NAB partnership pilot and launching AI features.

DroneShield Limited reported record revenue of $125.8 million for the half-year ended June 2026, driven by recurring income and geographic diversification, while posting a $32.2 million statutory loss due to margin pressure and strategic investments.

Calix Limited posted a 16% revenue increase to $39.2 million in FY26 driven by strong growth in its Magnesia business, while reporting a substantial net loss of $51 million largely due to a one-off impairment. The company advanced key industrial decarbonisation projects and strengthened strategic partnerships, focusing on capital-light commercialisation.

Mastermyne Group Limited (ASX:MYE) delivered a robust FY26 with revenue up 13% to $237.7 million and underlying profit before tax surging 148% to $15.7 million, supported by contract wins and a record order book.

Netwealth Group posted record FY26 revenue of $391 million, up 21%, with adjusted net profit rising 16.2% to $135.4 million after excluding $105 million in First Guardian compensation. The company declared a fully franked 21-cent final dividend, maintaining a 9.1% increase in total dividends.

HMC Capital reported a statutory loss of $111.6 million for FY26 amid significant fair value losses, yet delivered operating earnings close to guidance and maintained its dividend. The group’s strategic partnerships and capital recycling position it for a 16% rise in underlying earnings in FY27.

Camplify Holdings slashed its net loss by 95% in FY26, posting a second-half profit driven by cost cuts and the MyWay Mutual insurance launch, setting a foundation for growth in FY27.

Airtasker has secured $11 million in media capital through convertible notes with oOh!media and NOVA to accelerate brand growth across Australia, supporting recent strong revenue and marketplace gains.

Monvia Limited reported a $28.7 million revenue year with a $6.9 million adjusted EBITDA, exceeding IPO forecasts, while renewing a $60 million contract with MetLife and completing its ASX listing.

NeuroScientific Biopharmaceuticals posted a $4.69 million loss for FY2026, driven by R&D ramp-up and clinical progress with its StemSmart™ platform, while halting independent development of its glaucoma drug EmtinB to pursue licensing deals.

Terragen Holdings posted a slight increase in net loss to AUD 3.75 million for FY2026, while advancing key commercial trials and securing a $7 million equity raise to fuel growth.

International Graphite is advancing Australia’s first commercial graphite micronising plant at Collie, targeting commissioning by mid-2027. The facility promises a diverse range of superfine graphite products and potential annual EBITDA up to AUD 14.2 million based on current market conditions.